Krystexxa 8 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FP6D5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,482
Award facts
- Contract value 100% obligated
- $52,482.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $52,482 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Krystexxa 8 mg/mL vials. This non-set-aside contract, awarded on July 23, 2025, with completion targeted for August 13, 2025, represents a routine pharmaceutical procurement through the DLA's medical supply chain. The award is a child delivery order issued under AmerisourceBergen Drug Corp's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains significant federal contracting capabilities as a critical vendor for military and veteran healthcare systems. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Krystexxa, a specialty pharmaceutical used in gout treatment, exemplifies the company's role in fulfilling specialized medical product requirements through the DLA's competitive federal procurement process.
Quick answers
Who was awarded contract SPE2DB25FP6D5?
SPE2DB25FP6D5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FP6D5 worth?
The government has obligated $52,482 on SPE2DB25FP6D5.
Is contract SPE2DB25FP6D5 an order under another contract?
Yes. SPE2DB25FP6D5 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP6D5 competed?
The extent of competition for SPE2DB25FP6D5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award